Report an error

Spotted something inaccurate in “Phase 1 Trial Shows SOD1-Targeting siRNA Conjugate Safe in ALS Patients”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.